3 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Terminated 3 |
Follow Opioid Use Disorder: new trials by email Literature Review of Opioid Use Disorder trials Research Report on Opioid Use Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Test Whether BI 1356225 Improves Impulsive Behavior in People With Opioid Use Disorder Who Are Taking Buprenorphine BI 1356225, Placebo - Opioid Use Disorder | Phase 1 | Terminated | Boehringer Ingelheim | 12 | 2025-01-27 | 2026-07-31 |
| Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2). AZD4041, Itraconazole, Buprenorphine - Opioid Use Disorder | Phase 1 | Terminated | AstraZeneca | 15 | 2024-05-13 | 2025-03-26 |
| Ketamine for OUD and Comorbid Depression (OUDCD) Ketamine Hydrochloride - Opioid Use Disorder, Depressive Disorder | Phase 1 | Terminated | University of Maryland, Baltimore | 5 | 2022-04-04 | 2024-03-07 |
Opioid-Related Disorders (3) · Depressive Disorder (1)
Chemically-Induced Disorders (3) · Mental Disorders (3) · Narcotic-Related Disorders (3) · Substance-Related Disorders (3) · Mood Disorders (1)
Buprenorphine (1) · Buprenorphine, Naloxone Drug Combination (1) · Hydromorphone (1) · Itraconazole (1) · Ketamine (1)
AstraZeneca (1) · Boehringer Ingelheim (1) · University of Maryland, Baltimore (1)
United States (3)